Back to search

Article

Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations

2023-04-03

Abstract excerpt

<h4>ABSTRACT</h4> Tuberculosis (TB), caused by Mycobacterium tuberculosis ( Mtb ), remains a leading cause of death with 1.6 million deaths worldwide reported in 2021. Oral pyrazinamide (PZA) is an integral part of anti-TB regimens, but its prolonged use has the potential to drive development of PZA resistant Mtb . PZA is converted to the active moiety pyrazinoic acid (POA) by the Mtb pyrazinamidase encoded b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7986f3b7-e1ba-5516-917d-0c4fbfb5f729
DOI
10.1101/2023.04.01.534965
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulationsDOI 10.1101/2023.04.01.534965
Select a neighboring publication to make it the new centre.